Researchers found no detectable levels of semaglutide in breast milk, suggesting minimal risk to breastfed infants, but highlighted the need for monitoring maternal nutrition and milk production.
Shanghai startup’s gene therapy restores hearing in five deaf children, running ahead of Lilly and Regeneron trials
Five of six children who had been deaf since or soon after birth can now hear after receiving a gene therapy developed by Shanghai Refreshgene
January 26, 2024